tiprankstipranks
Advertisement
Advertisement

AMRX Stock Latest News

Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans
Company AnnouncementsAmneal Stockholders Approve Kashiv BioSciences Acquisition Plans
8h ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
18h ago
AMRX
Amneal Raises 2026 Outlook After Strong Q2 Results
PremiumCompany Announcements
Amneal Raises 2026 Outlook After Strong Q2 Results
2d ago
8K
AMRX
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
PremiumThe Fly
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
2d ago
AMRX
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
PremiumThe Fly
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
2d ago
AMRX
Amneal receives FDA approval for additional iohexol strengths, presentations
PremiumThe FlyAmneal receives FDA approval for additional iohexol strengths, presentations
15d ago
AMRX
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
Premium
The Fly
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
17d ago
AMRX
FDA selects seven participants for PreCheck Pilot Program
Premium
The Fly
FDA selects seven participants for PreCheck Pilot Program
1M ago
LLY
AMRX
Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says
PremiumThe Fly
Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says
1M ago
LLY
AMRX
Zambon, Amneal Pharmaceuticals announce CHMP opinion recommending Hopledo
PremiumThe Fly
Zambon, Amneal Pharmaceuticals announce CHMP opinion recommending Hopledo
1M ago
AMRX
5 Reasons to Be Bullish on Stocks
PremiumMarket News
5 Reasons to Be Bullish on Stocks
2M ago
AMRX
AVAH
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
PremiumThe Fly
Amneal Pharmaceuticals announces interim results from ELEVATE-PD study
2M ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
PremiumThe FlyAmneal Pharmaceuticals announces FDA approval of romidepsin injection solution
2M ago
AMRX
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
Premium
The Fly
Amneal Pharmaceuticals announces FDA approval of romidepsin injection solution
2M ago
AMRX
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
Premium
The Fly
Amneal Pharmaceuticals price target raised to $16 from $15 at Barclays
2M ago
AMRX
Amneal Pharma Bets Big on Biosimilars in Q1 Call
PremiumCompany Announcements
Amneal Pharma Bets Big on Biosimilars in Q1 Call
2M ago
AMRX
Amneal Shareholders Back Board, Pay and Auditor at Meeting
PremiumCompany Announcements
Amneal Shareholders Back Board, Pay and Auditor at Meeting
3M ago
8K
AMRX
Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
PremiumThe Fly
Amneal Pharmaceuticals reports Q1 EPS 27c, consensus 17c
3M ago
AMRX
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
PremiumThe Fly
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
3M ago
AMRX
Amneal Pharma Bets Big On Biosimilars Growth
PremiumCompany AnnouncementsAmneal Pharma Bets Big On Biosimilars Growth
3M ago
AMRX
Is AMRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is AMRX a Buy, Before Earnings?
3M ago
AMRX
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
Premium
Company Announcements
Amneal to Acquire Kashiv, Expanding Biosimilars Platform
3M ago
8K
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >